Medical costs and health care utilization in Dutch diabetes patients with high levels of diabetes-distress

IF 2.9 3区医学 Q3 ENDOCRINOLOGY & METABOLISM

Journal of diabetes and its complications Pub Date : 2025-05-21 DOI:10.1016/j.jdiacomp.2025.109086

Charlotte B. Schmidt , Eva Keijsper , Judith E. Bosmans , Bert Jan Potter van Loon , Frank J. Snoek , Adriaan Honig

{"title":"Medical costs and health care utilization in Dutch diabetes patients with high levels of diabetes-distress","authors":"Charlotte B. Schmidt , Eva Keijsper , Judith E. Bosmans , Bert Jan Potter van Loon , Frank J. Snoek , Adriaan Honig","doi":"10.1016/j.jdiacomp.2025.109086","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>Diabetes-distress is prevalent in persons with diabetes. However, studies on the association between diabetes-distress, costs and healthcare utilization are scarce. We aim to explore whether diabetes-distress is related to healthcare utilization and medical costs.</div></div><div><h3>Methods</h3><div>In this cross-sectional study, diabetes patients completed the Problem Areas in Diabetes Short Form (PAID5) and the Patient Health Questionnaire (PHQ9). Healthcare utilization (in number of yearly visits) was measured using the Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness (TiC-P), and extraction from the hospital's medical records. Healthcare costs were calculated using Dutch standard costs. Generalized linear models (Gamma log link) were used to estimate the associations while adjusting for confounders.</div></div><div><h3>Results</h3><div>Diabetes-distress was related to healthcare utilization, mean difference 10, 95 % CI 9 to 14, but not to healthcare costs, mean difference €467, 95 % CI -71 to 1006. When controlling for depressive symptoms, comorbidity, age, ethnicity, socioeconomic status and diabetes duration, diabetes-distress remained associated with healthcare utilization, mean difference 9, 95 % CI 2 to 16.</div></div><div><h3>Conclusions</h3><div>This is the first study to evaluate associations between diabetes-distress and healthcare utilization and costs in diabetes patients. Diabetes-distress was significantly related to an increased amount of healthcare utilization, but not costs.</div></div>","PeriodicalId":15659,"journal":{"name":"Journal of diabetes and its complications","volume":"39 8","pages":"Article 109086"},"PeriodicalIF":2.9000,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of diabetes and its complications","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1056872725001394","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Aims

Diabetes-distress is prevalent in persons with diabetes. However, studies on the association between diabetes-distress, costs and healthcare utilization are scarce. We aim to explore whether diabetes-distress is related to healthcare utilization and medical costs.

Methods

In this cross-sectional study, diabetes patients completed the Problem Areas in Diabetes Short Form (PAID5) and the Patient Health Questionnaire (PHQ9). Healthcare utilization (in number of yearly visits) was measured using the Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness (TiC-P), and extraction from the hospital's medical records. Healthcare costs were calculated using Dutch standard costs. Generalized linear models (Gamma log link) were used to estimate the associations while adjusting for confounders.

Results

Diabetes-distress was related to healthcare utilization, mean difference 10, 95 % CI 9 to 14, but not to healthcare costs, mean difference €467, 95 % CI -71 to 1006. When controlling for depressive symptoms, comorbidity, age, ethnicity, socioeconomic status and diabetes duration, diabetes-distress remained associated with healthcare utilization, mean difference 9, 95 % CI 2 to 16.

Conclusions

This is the first study to evaluate associations between diabetes-distress and healthcare utilization and costs in diabetes patients. Diabetes-distress was significantly related to an increased amount of healthcare utilization, but not costs.

查看原文本刊更多论文

荷兰糖尿病患者高水平糖尿病痛苦的医疗费用和卫生保健利用

目的糖尿病痛苦在糖尿病患者中很普遍。然而，关于糖尿病困扰、成本和医疗保健利用之间关系的研究很少。我们的目的是探讨糖尿病痛苦是否与医疗保健利用和医疗费用有关。方法在横断面研究中，糖尿病患者填写糖尿病问题领域短表（PAID5）和患者健康问卷（PHQ9）。使用Trimbos和iMTA精神疾病相关费用问卷（TiC-P）以及从医院医疗记录中提取的数据来测量医疗保健利用率（按年就诊次数计算）。医疗保健费用采用荷兰标准费用计算。在调整混杂因素时，使用广义线性模型（伽马对数链接）来估计关联。结果糖尿病痛苦与医疗保健利用相关，平均差值为10,95% CI为9 ~ 14；与医疗保健费用无关，平均差值为467,95% CI为-71 ~ 1006。在控制抑郁症状、合并症、年龄、种族、社会经济地位和糖尿病病程后，糖尿病窘迫仍与医疗保健利用相关，平均差异为9,95% CI 2 ~ 16。结论本研究首次评估了糖尿病患者的糖尿病痛苦与医疗保健利用和成本之间的关系。糖尿病痛苦与医疗保健使用量的增加显著相关，但与成本无关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of diabetes and its complications 医学-内分泌学与代谢

CiteScore

5.90

自引率

3.30%

发文量

153

审稿时长

16 days

期刊介绍： Journal of Diabetes and Its Complications (JDC) is a journal for health care practitioners and researchers, that publishes original research about the pathogenesis, diagnosis and management of diabetes mellitus and its complications. JDC also publishes articles on physiological and molecular aspects of glucose homeostasis. The primary purpose of JDC is to act as a source of information usable by diabetes practitioners and researchers to increase their knowledge about mechanisms of diabetes and complications development, and promote better management of people with diabetes who are at risk for those complications. Manuscripts submitted to JDC can report any aspect of basic, translational or clinical research as well as epidemiology. Topics can range broadly from early prediabetes to late-stage complicated diabetes. Topics relevant to basic/translational reports include pancreatic islet dysfunction and insulin resistance, altered adipose tissue function in diabetes, altered neuronal control of glucose homeostasis and mechanisms of drug action. Topics relevant to diabetic complications include diabetic retinopathy, neuropathy and nephropathy; peripheral vascular disease and coronary heart disease; gastrointestinal disorders, renal failure and impotence; and hypertension and hyperlipidemia.